Stock Track | BIOSTAR PHARM-B Plummets 9.09% Intraday on Audit Concerns Over Investment Fund Recoverability

Stock Track

03/26

BIOSTAR PHARM-B's stock plummeted 9.09% during intraday trading on Thursday, following the company's announcement of potential audit issues related to an investment fund.

The pharmaceutical company warned that its auditors may issue a qualified opinion on the forthcoming annual results due to uncertainties surrounding the recoverability of an investment fund. This announcement has raised significant accounting concerns among investors about the company's financial health.

Beijing Biostar stated it is currently engaging with auditors to resolve the matter and will provide additional information in its full-year results announcement. The board has advised shareholders and potential investors to exercise caution when dealing in the company's shares.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1124159228"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124159228\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124159228?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 09:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124159228","market":"sg","top_or_hot":-1,"title":"Stock Track | BIOSTAR PHARM-B Plummets 9.09% Intraday on Audit Concerns Over Investment Fund Recoverability","media":"Stock Track","content":"<p>BIOSTAR PHARM-B's stock plummeted 9.09% during intraday trading on Thursday, following the company's announcement of potential audit issues related to an investment fund.</p><p>The pharmaceutical company warned that its auditors may issue a qualified opinion on the forthcoming annual results due to uncertainties surrounding the recoverability of an investment fund. This announcement has raised significant accounting concerns among investors about the company's financial health.</p><p>Beijing Biostar stated it is currently engaging with auditors to resolve the matter and will provide additional information in its full-year results announcement. The board has advised shareholders and potential investors to exercise caution when dealing in the company's shares.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BIOSTAR PHARM-B Plummets 9.09% Intraday on Audit Concerns Over Investment Fund Recoverability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BIOSTAR PHARM-B Plummets 9.09% Intraday on Audit Concerns Over Investment Fund Recoverability\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-26 09:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BIOSTAR PHARM-B's stock plummeted 9.09% during intraday trading on Thursday, following the company's announcement of potential audit issues related to an investment fund.</p><p>The pharmaceutical company warned that its auditors may issue a qualified opinion on the forthcoming annual results due to uncertainties surrounding the recoverability of an investment fund. This announcement has raised significant accounting concerns among investors about the company's financial health.</p><p>Beijing Biostar stated it is currently engaging with auditors to resolve the matter and will provide additional information in its full-year results announcement. The board has advised shareholders and potential investors to exercise caution when dealing in the company's shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02563","symbol_name":"华昊中天医药-B","start_time":0,"source_url":"","article_id":"1124159228","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124159228","pubTimestamp":1774489712,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BIOSTAR PHARM-B's stock plummeted 9.09% during intraday trading on Thursday, following the company's announcement of potential audit issues related to an investment fund.The pharmaceutical company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02563":"华昊中天医药-B"},"translate_title":"个股追踪|映泰医药-B盘中暴跌9.09%审计担忧投资基金可收回性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02563":1},"content_text":"BIOSTAR PHARM-B's stock plummeted 9.09% during intraday trading on Thursday, following the company's announcement of potential audit issues related to an investment fund.The pharmaceutical company warned that its auditors may issue a qualified opinion on the forthcoming annual results due to uncertainties surrounding the recoverability of an investment fund. This announcement has raised significant accounting concerns among investors about the company's financial health.Beijing Biostar stated it is currently engaging with auditors to resolve the matter and will provide additional information in its full-year results announcement. The board has advised shareholders and potential investors to exercise caution when dealing in the company's shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}